LBTD Stock Chart & Stats
$0.01
$0.00(0.00%)
At close: 4:00 PM EST
$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.01 - $0.01
Previous CloseN/A
Volume7.00K
Average Volume (3M)0.00
Market Cap
$783.00
Enterprise Value$8.07M
Total Cash (Recent Filing)$50.01K
Total Debt (Recent Filing)$16.68K
Price to Earnings (P/E)―
Beta0.00
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding782,775,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio6.06
Price to Book (P/B)-189.02
Price to Sales (P/S)0.00
P/FCF Ratio-652.69
Enterprise Value/Market Cap10.31K
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-10.41
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
LBTD FAQ
What was Lotus Bio-Technology Development Corp.’s price range in the past 12 months?
Lotus Bio-Technology Development Corp. lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is Lotus Bio-Technology Development Corp.’s market cap?
Lotus Bio-Technology Development Corp.’s market cap is $783.00.
When is Lotus Bio-Technology Development Corp.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Lotus Bio-Technology Development Corp.’s earnings last quarter?
Lotus Bio-Technology Development Corp. released its earnings results on Feb 13, 2018. The company reported $0 earnings per share for the quarter, the consensus estimate of N/A by $0.
Is Lotus Bio-Technology Development Corp. overvalued?
According to Wall Street analysts Lotus Bio-Technology Development Corp.’s price is currently Overvalued.
Does Lotus Bio-Technology Development Corp. pay dividends?
Lotus Bio-Technology Development Corp. does not currently pay dividends.
What is Lotus Bio-Technology Development Corp.’s EPS estimate?
Lotus Bio-Technology Development Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lotus Bio-Technology Development Corp. have?
Lotus Bio-Technology Development Corp. has 782,775,000 shares outstanding.
What happened to Lotus Bio-Technology Development Corp.’s price movement after its last earnings report?
Lotus Bio-Technology Development Corp. reported an EPS of $0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Lotus Bio-Technology Development Corp.?
Currently, no hedge funds are holding shares in LBTD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Lotus Bio-Technology Development Corp.
Lotus Bio-Technology Development Corp. (LBTD) operates as a biotechnology firm, primarily dedicated to the processing of organic substances and the creation of natural consumer products for the Chinese market. This entity, which began its operations in 2011, was formerly recognized as Starflick.com before officially adopting its current name in April 2016. Its main corporate offices are located in Cave Creek, Arizona.